City page
Espoo biotech and pharma directory
This page shows why the city matters, which categories are strongest there, and which compliance or quality markers are already visible in public evidence.
Where does this city read strongest?
Diagnostics (2), Therapeutics (2), and Manufacturing (1). Most visible records: Desentum, Herantis Pharma, and Blueprint Genetics.
Which standards and public evidence are already visible?
GMP (1) and ISO-13485 (2). Latest review: 22 March 2026. Review cycle: March 2026.
Why does this city matter?
This page brings visible companies and infrastructure records into one practical view of Espoo.
By category
Espoo by category
Jump into a category page filtered to this country only.
Full list
Espoo biotech and pharma directory
6 city records currently match the active filter.
Current review cycle
Desentum
EspooFinlandTherapeutics
Espoo clinical-stage biopharmaceutical company developing next-generation allergen immunotherapy products from a Finnish operating base.
- Lead
- Pekka MattilaCEO
- Scale
- Clinical-stage therapeutics platform
Current review cycle
Herantis Pharma
EspooFinlandTherapeutics
Espoo therapeutics company developing biologic candidates for neuroinflammation and CNS disorders from a Finnish biotech platform.
- Lead
- Antti VuolantoCEO
- Scale
- Clinical-stage biotech therapeutics platform
Current review cycle
Blueprint Genetics
EspooFinlandGenomics
Espoo genetic-testing and genomic-diagnostics laboratory delivering rare-disease panels, exome and genome sequencing, and accredited clinical interpretation from Finland.
- Lead
- Juhana RauramoVice President and General Manager; Managing Director
- Scale
- Global clinical genetic testing from Espoo
Current review cycle
Aidian
EspooFinlandDiagnostics
Espoo IVD headquarters developing and manufacturing point-of-care, molecular-diagnostics, microbiology, and hygiene-monitoring products under ISO 13485 and IVDR-aligned quality systems.
- Lead
- Antti KoivulaCEO (interim) and CFO
- Scale
- Global IVD manufacturing and distribution support
Current review cycle
Medix Biochemica
EspooFinlandDiagnostics
Espoo IVD raw-material headquarters and manufacturing base supplying antibodies, antigens, and assay inputs for diagnostic developers.
- Lead
- Steve FergusonChief Executive Officer
- Scale
- Industrial IVD raw-material manufacturing
Current review cycle
Orion Corporation
EspooFinlandManufacturing
Espoo-headquartered pharmaceutical company combining API production, formulation, and neuroscience-focused R&D with regulated Finnish manufacturing operations.
- Lead
- Liisa HurmePresident and CEO
- Scale
- Global Market
Related briefs
Briefs that mention Espoo
Nordic Biotech Landscape 2026: Denmark, Sweden, Finland, Norway
A practical map of the Nordic biotech and pharma landscape in 2026 — 124 operators across Denmark, Sweden, Finland, and Norway, anchored by Novo Nordisk, Genmab, Lundbeck, AstraZeneca Gothenburg, Bavarian Nordic, Orion, and a dense Medicon Valley + Karolinska cluster layer.
Open briefEuropean Vaccines Landscape 2026: Biodefence, mRNA, Allergen, Infectious Disease
A practical map of the European vaccines sector in 2026 — Bavarian Nordic MVA-BN biodefence, BioNTech and CureVac mRNA, ALK-Abelló allergen immunotherapy, Valneva infectious-disease vaccines, Statens Serum Institut, plus a specialised clinical-stage innovator layer.
Open briefEuropean Genomics & Sequencing 2026: NGS, CRISPR, NIPT, Single-Cell
A practical map of the European genomics and sequencing sector in 2026 — Estonian Genome Center, CasZyme CRISPR-Cas, Blueprint Genetics NGS diagnostics, CeGaT, Asper Biogene, plus the Baltic + Nordic single-cell and NIPT layer.
Open briefNext step
Read the city, then widen the view.
Use country and regional pages for wider context, and the company suggestion form for new candidate records.